Overview
Ryuichi Harada practices in Sendai, Japan. Mr. Harada is rated as an Advanced expert by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. His top areas of expertise are Alzheimer's Disease, Dementia, Progressive Supranuclear Palsy Atypical, and Progressive Supranuclear Palsy.
His clinical research consists of co-authoring 72 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Progressive Supranuclear Palsy Atypical.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Alzheimer's DiseaseMr. Harada isDistinguished. Learn about Alzheimer's Disease.
- DementiaMr. Harada isDistinguished. Learn about Dementia.
- Advanced
- Brown SyndromeMr. Harada isAdvanced. Learn about Brown Syndrome.
- Progressive Supranuclear PalsyMr. Harada isAdvanced. Learn about Progressive Supranuclear Palsy.
- Progressive Supranuclear Palsy Atypical
- Experienced
- Corticobasal DegenerationMr. Harada isExperienced. Learn about Corticobasal Degeneration.
- Frontotemporal DementiaMr. Harada isExperienced. Learn about Frontotemporal Dementia.
- Movement DisordersMr. Harada isExperienced. Learn about Movement Disorders.
- Parkinson's DiseaseMr. Harada isExperienced. Learn about Parkinson's Disease.
- Supranuclear OphthalmoplegiaMr. Harada isExperienced. Learn about Supranuclear Ophthalmoplegia.